| GFACX | SGRAX | GFACX / SGRAX | |
| Total Expense Ratio | 1.35 | 1.12 | 121% |
| Annual Report Gross Expense Ratio | 1.35 | 1.17 | 115% |
| Fund Existence | 25 years | 27 years | - |
| Gain YTD | 8.915 | 1.741 | 512% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 342B | 2.9B | 11,797% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 2.93 | -29.66 | -10% |
| Returns for 3 years | 38.51 | -26.02 | -148% |
| Returns for 5 years | 7.51 | -58.63 | -13% |
| Returns for 10 years | 77.91 | -55.03 | -142% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MSOS | 4.96 | 0.22 | +4.64% |
| AdvisorShares Pure US Cannabis ETF | |||
| LSAT | 47.49 | 0.46 | +0.98% |
| LeaderShares® AlphaFctr® Tctcl Fcsd ETF | |||
| QQQM | 293.76 | 0.97 | +0.33% |
| Invesco NASDAQ 100 ETF | |||
| UJAN | 46.10 | 0.07 | +0.15% |
| Innovator US Equity Ultra Buff ETF™ Jan | |||
| CPRA | 27.88 | N/A | N/A |
| Calamos Russell 2000 Str Alt Prt ETF-Apr | |||